Meeting Abstract

Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH)


AutorenlisteGhofrani, Hossein-Ardeschir; Grimminger, Friedrich; Hoeper, Marius M.; Kim, Nick H.; Mayer, Eckhard; Simonneau, Gerald; Sikirica, Mirko; Fritsch, Arno; Davie, Neil; Luong, Ba; Wilkins, Martin R.

Jahr der Veröffentlichung2013

ZeitschriftEuropean Respiratory Journal

Bandnummer42

ISSN0903-1936

eISSN1399-3003

VerlagEuropean Respiratory Society



Zitierstile

Harvard-ZitierstilGhofrani, H., Grimminger, F., Hoeper, M., Kim, N., Mayer, E., Simonneau, G., et al. (2013) Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH), European Respiratory Journal, 42

APA-ZitierstilGhofrani, H., Grimminger, F., Hoeper, M., Kim, N., Mayer, E., Simonneau, G., Sikirica, M., Fritsch, A., Davie, N., Luong, B., & Wilkins, M. (2013). Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH). European Respiratory Journal. 42.



Schlagwörter


Pulmonary hypertensionQuality of lifeTreatments

Zuletzt aktualisiert 2025-02-04 um 02:25